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 Epilepsy is a serious chronic disease affecting all ages which can be 
characterized by recurrent epileptic attacks. It affects about 1,3-4 % of the population 
and endangers the patient's life at every incoming attack. Long-term treatment must be 
preceded by thorough diagnosis and classification of the disease, which can be very 
difficult. The aim of the treatment is to prevent recurrent epileptic attacks, or at least 
mitigate them while minimizing the side effects of the treatment and reducing the 
negative impact on the quality of life. When choosing a suitable drug for an adult, the 
doctor usually decides individually depending on the type of epileptic attack. In 
children, the choice of the treatment often depends on the diagnosed type of syndrome, 
which appears more in the lower age category than in adult patients. The doctor should 
follow expert standards of the treatment of epilepsy, and also their own most recent 
experience and knowledge gained during the course of lifelong learning. The therapy 
begins with monotherapy, and only when not successful, it is necessary to proceed to 
polytherapy with more drugs.  Antiepileptic drugs may be divided into three categories 
to classical pharmaceuticals, newer pharmaceuticals, and those in various stages of 
clinical research possessing anticonvulsant potential. Neurosurgical treatment is 
individually indicated in pharmacoresistant epilepsy. Such treatment can remove the 
underlying cause of the illness and cure the patient completely. Non-pharmacological 
therapy, which includes psychological help, EEG biofeedback and ketogenic diet only 
complement the anticonvulsants. 
 
